P Dayer - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P Dayer

Showing results (161-170 of 163) with videos related to

Pageof 17

Sort By:

You have reached the last page of results.This site can display upto 163 results.

Pharmacogenetics|February 18, 1999

An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in CaucasiansG C Ibeanu, J Blaisdell, B I Ghanayem, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998

A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoinR J Ferguson, S M De Morais, S Benhamou, et al.

Schweizerische Medizinische Wochenschrift|June 4, 1994

Medical-ethical guidelines for genetic investigations in humansH J Müller, Th Deonna, I Abbt, et al.

Pageof 17

Search research articles

Showing results (161-170 of 163) with videos related to

Sort By:

Pageof 17

You have reached the last page of results.This site can display upto 163 results.

Pharmacogenetics|February 18, 1999

An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in CaucasiansG C Ibeanu, J Blaisdell, B I Ghanayem, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998

A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoinR J Ferguson, S M De Morais, S Benhamou, et al.

Schweizerische Medizinische Wochenschrift|June 4, 1994

Medical-ethical guidelines for genetic investigations in humansH J Müller, Th Deonna, I Abbt, et al.

Pageof 17